Mr. Andre Larente reports

DIAGNOS ANNOUNCES MAJOR ADVANCES IN CYBERSECURITY CERTIFICATION BY THE CYBER DEFENSE OPERATIONS CENTER (COCD) FOR ITS CARA SYSTEM APPLICATION

Diagnos Inc. has made major advances in cybersecurity certification by the cyber defence operations centre (COCD) for its CARA system application.

As part of its continuing ISO 27001 certification process, Diagnos is pleased to announce that its CARA system application has recently undergone a series of extensive penetration tests, in accordance with the cybersecurity requirements of the Quebec Ministry of Health. The vulnerabilities identified during these tests were rapidly corrected following regression tests carried out in early March, 2025. These measures enabled Diagnos to receive a positive assessment of CARA's security posture from the COCD, underlining compliance with stringent cybersecurity standards.

An official notification has been sent to Quebec's health care institutions, including CISSS (integrated health and social services centres) and CIUSSS (integrated university health and social services centres), as well as CHUM (Centre hospitalier de l'Universite de Montreal), authorizing them to integrate CARA into their projects.

"Protecting personal data is at the heart of our commitment to our customers. The successful completion of our intrusion test validated by Quebec's Centre operationnel de cybersecurite gouvernemental (COCD) is indisputable proof of the high level of security of our CARA application. This test marks a key step in our drive to obtain ISO 27001 certification. The planned verification audit will be decisive in confirming our ongoing efforts and commitment to the highest standards of cybersecurity. Our users can have total confidence in our rigorous standards to protect their information," stated Andre Larente, chief executive officer of Diagnos.

In addition, Diagnos is also proud to announce that its ISO 27001 certification process is progressing according to plan. Audit dates with certification body Intertek have been set, and an update will be published over the summer.

About Diagnos Inc.

Diagnos is a publicly traded Canadian corporation dedicated to early detection of critical eye-related health problems. By leveraging artificial intelligence, Diagnos aims to provide more information to health care clinicians to enhance diagnostic accuracy, streamline work flows and improve patient outcomes on a global scale.

We seek Safe Harbor.